Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Masami Kawamura"'
Autor:
Kanako Shimizu, Shogo Ueda, Masami Kawamura, Honoka Aoshima, Mikiko Satoh, Jun Nakabayashi, Shin-ichiro Fujii
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)
Background A key to success of cancer immunotherapy is the amplification and sustenance of various effector cells. The hallmark of prominent antitumor T cells is their long-term effector function. Although interleukin (IL)-2 is an attractive cytokine
Externí odkaz:
https://doaj.org/article/ce241bf8380c4bea8f2b33d17353cf63
Autor:
Kanako Shimizu, Satoru Yamasaki, Maki Sakurai, Noriko Yumoto, Mariko Ikeda, Chiemi Mishima-Tsumagari, Mutsuko Kukimoto-Niino, Takashi Watanabe, Masami Kawamura, Mikako Shirouzu, Shin-ichiro Fujii
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Granzyme A (GzmA), together with perforin, are well-known for their cytotoxic activity against tumor or virus-infected cells. In addition to this cytotoxic function, GzmA stimulates several immune cell types and induces inflammation in the absence of
Externí odkaz:
https://doaj.org/article/21f69a4dc1de49c8bbf8bb671bd36d5c
Autor:
Kanako Shimizu, Jun Shinga, Satoru Yamasaki, Masami Kawamura, Jan Dörrie, Niels Schaft, Yusuke Sato, Tomonori Iyoda, Shin-Ichiro Fujii
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0131477 (2015)
Cell-based therapies using genetically engineered lymphocytes expressing antigen-specific T cell receptors (TCRs) hold promise for the treatment of several types of cancers. Almost all studies using this modality have focused on transfer of TCR from
Externí odkaz:
https://doaj.org/article/f76654aa0db14c60a213a5dd7ababac4
Autor:
Tomonori Iyoda, Kanako Shimizu, Masami Kawamura, Jun Shinga, Takashi Watanabe, Koya Fukunaga, Taisei Mushiroda, Hideo Saka, Chiyoe Kitagawa, Shin-ichiro Shimamatsu, Mitsuhiro Takenoyama, Youko Suehiro, Takumi Imai, Ayumi Shintani, Suminobu Ito, Shin-ichiro Fujii
Publikováno v:
ImmunoHorizons. 7:1-16
NK cells are major effector cells involved in the elimination of early tumors and prevent metastasis. They often have an impaired function in patients with cancer. Preclinical studies have demonstrated NK cell activation as the adjunctive effect of i
Autor:
Shin-ichiro Fujii, Toyotaka Kawamata, Kanako Shimizu, Jun Nakabayashi, Satoru Yamasaki, Tomonori Iyoda, Jun Shinga, Hiroshi Nakazato, An Sanpei, Masami Kawamura, Shogo Ueda, Jan Dörrie, Svetlana Mojsov, Madhav V. Dhodapkar, Michihiro Hidaka, Masanori Nojima, Fumitaka Nagamura, Shigemi Yoshida, Toshio Goto, Arinobu Tojo
Publikováno v:
Molecular Therapy - Oncolytics. 27:315-332
Publikováno v:
Cancer Science. 113:2536-2547
The efficacy of current coronavirus disease 2019 (COVID-19) vaccines has been demonstrated; however, emerging evidence suggests insufficient protection in certain immunocompromised cancer patients. We previously developed a cell-based anti-cancer vac
Autor:
Shin‐ichiro Fujii, Satoru Yamasaki, Kenichi Hanada, Shogo Ueda, Masami Kawamura, Kanako Shimizu
Publikováno v:
Cancer science. 113(3)
NY-ESO-1 is a cancer/testis antigen expressed in various cancer types. However, the induction of NY-ESO-1-specific CTLs through vaccines is somewhat difficult. Thus, we developed a new type of artificial adjuvant vector cell (aAVC-NY-ESO-1) expressin
Autor:
Osamu Ohara, Yusuke Sato, Kanako Shimizu, Takashi Watanabe, Shin-ichiro Fujii, Hiroshi Nakazato, Masami Kawamura
Publikováno v:
Communications Biology
Communications Biology, Vol 2, Iss 1, Pp 1-13 (2019)
Communications Biology, Vol 2, Iss 1, Pp 1-13 (2019)
Eomes regulates the differentiation of CD8+ T cells into effector and memory phases. However, its role in invariant (i)NKT cells remains unknown. Here, we show the impact of Eomes on iNKT cells in the thymus and peripheral tissue using conditional kn
Autor:
Mikako Shirouzu, Mutsuko Kukimoto-Niino, Satoru Yamasaki, Maki Sakurai, Chiemi Mishima-Tsumagari, Noriko Yumoto, Takashi Watanabe, Shin-ichiro Fujii, Masami Kawamura, Mariko Ikeda, Kanako Shimizu
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 10 (2019)
Frontiers in Immunology, Vol 10 (2019)
Granzyme A (GzmA), together with perforin, are well-known for their cytotoxic activity against tumor or virus-infected cells. In addition to this cytotoxic function, GzmA stimulates several immune cell types and induces inflammation in the absence of
Autor:
Masami Kawamura, Yoshihiro Ito, Satoru Yamasaki, Kon Son, Tomonori Iyoda, Motoki Ueda, Shin-ichiro Fujii, Kanako Shimizu
Publikováno v:
Cancer Science
Recent immunotherapies have shown clinical success. In particular, vaccines based on particulate antigen (Ag) are expected to be implemented based on their efficacy. In the current study, we describe a strategy entailing Ag-encapsulating PEG-modified